Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo
A. Moschetta et al., Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo, J HEPATOL, 34(4), 2001, pp. 492-499
Background/Aims: The hepatocyte canalicular membrane enter leaflet contains
both phosphatidylcholine (PC) and sphingomyelin (SM). Normally, PC is the
exclusive phospholipid in bile. We examined effects of bile salt hydrophobi
city on cytotoxicity and on differential SM and PC distribution between det
ergent-resistant aggregated vesicles (model for detergent-resistant canalic
ular membrane) and mixed micelles or small unilamellar vesicles (representi
ng lipid phases in bile).
Methods: Aggregated vesicles were obtained by ultracentrifugation of choles
terol-supersaturated model systems containing SM, PC and various bile salts
, micelles by ultrafiltration and unilamellar vesicles by dialysis of the s
upernatant. Erythrocyte hemolysis and lactate dehydrogenase release from Ca
Co-2 cells upon incubation with various micelles were quantified.
Results: Preferential SM distribution and lipid solubilization in aggregate
d vesicles increased in rank order taurodeoxycholate < taurocholate < tauro
ursodeoxycholate < taurohyodeoxycholate, with reciprocal PC enrichment in m
icelles and small unilamellar vesicles. Including small amounts of PC withi
n taurohyodeoxycholate micelles increased cytotoxicity with more erythrocyt
e hemolysis and LDH release from CaCo-2 cells upon incubation, but decrease
d cytotoxicity in case of tauroursodeoxycholate micelles.
Conclusions: Hydrophilic but not hydrophobic bile salts preserve integrity
of pathophysiologically relevant phosphatidylcholine plus sphingomyelin-con
taining bilayers. Enhanced biliary phospholipid secretion during taurohyode
oxycholate but not during tauroursodeoxycholate therapy (Hepatology 25 (199
7) 1306) may relate to different interactions of these bile salts with phos
pholipids. (C) 2001 European Association for the Study of the Liver. Publis
hed by Elsevier Science B.V. All rights reserved.